COVID-19 and Autoimmunity

Author: Gianpiero Pescarmona
Date: 12/12/2020



  • So far, there is no published research on rATG or similar heavy-duty transplant drugs for the treatment of Covid-19. “These are very powerful drugs, and there’s a risk you might endanger someone,” Icenogle says. Some doctors have been willing to test out comparatively mild immunosuppressant drugs, and at least one of those—*dexamethasone* — has worked. But Icenogle says that many in medicine regard the notion of depleting the immune system of a virus-stricken patient as “at least paradoxical, if not crazy.”

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019

Even in Mild Cases, Covid-19 Could Damage the Heart

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 19 06 2020

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 07 10 2020

Overlapping B cell pathways in severe COVID-19 and lupus 02 11 2020

COVID-19: Infection or Autoimmunity 11 09 2020

Aspirin May Treat Severe Covid-19 Disease, and That Tells Us Something Important 05 11 2020

Inflammation Cascade

  1. ROS
    • GSH
  2. Pospholipase A2
    • Dexamethasone
  3. COX
    • Aspirin and FANS
    • GSH
AddThis Social Bookmark Button